A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
Study sponsor: Ionis Pharmaceuticals, Inc. · IONS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-01-10Actual
Enrollment · participants160Actual
Source updated2024-11-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.